lipoxin a4 has been researched along with Osteoporosis, Postmenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Guan, H; Li, F; Liu, C; Xiao, J | 1 |
| Serhan, CN | 1 |
1 review(s) available for lipoxin a4 and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Clues for new therapeutics in osteoporosis and periodontal disease: new roles for lipoxygenases?
Topics: Animals; Animals, Genetically Modified; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Arteriosclerosis; Bone Remodeling; Eicosanoids; Enzyme Induction; Humans; Inflammation; Inflammation Mediators; Lipoxins; Lipoxygenase Inhibitors; Mice; Osteoporosis; Osteoporosis, Postmenopausal; Periodontitis; Rabbits; Recombinant Fusion Proteins | 2004 |
1 other study(ies) available for lipoxin a4 and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss.
Topics: Animals; Bone Resorption; Cathepsin K; Cell Line; Female; Humans; Lipoxins; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; NF-kappa B; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RANK Ligand; Reactive Oxygen Species; Tartrate-Resistant Acid Phosphatase | 2017 |